These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 32927077)

  • 1. Functionalized PLGA nanoparticles prepared by nano-emulsion templating interact selectively with proteins involved in the transport through the blood-brain barrier.
    Monge M; Fornaguera C; Quero C; Dols-Perez A; Calderó G; Grijalvo S; García-Celma MJ; Rodríguez-Abreu C; Solans C
    Eur J Pharm Biopharm; 2020 Nov; 156():155-164. PubMed ID: 32927077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PLGA nanoparticles prepared by nano-emulsion templating using low-energy methods as efficient nanocarriers for drug delivery across the blood-brain barrier.
    Fornaguera C; Dols-Perez A; Calderó G; García-Celma MJ; Camarasa J; Solans C
    J Control Release; 2015 Aug; 211():134-43. PubMed ID: 26057857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential use of polymeric nanoparticles for drug delivery across the blood-brain barrier.
    Tosi G; Bortot B; Ruozi B; Dolcetta D; Vandelli MA; Forni F; Severini GM
    Curr Med Chem; 2013; 20(17):2212-25. PubMed ID: 23458620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uptake of polymeric nanoparticles in a human induced pluripotent stem cell-based blood-brain barrier model: Impact of size, material, and protein corona.
    Onyema HN; Berger M; Musyanovych A; Bantz C; Maskos M; Freese C
    Biointerphases; 2021 Mar; 16(2):021004. PubMed ID: 33765771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue inhibitor of matrix metalloproteinases-1 loaded poly(lactic-co-glycolic acid) nanoparticles for delivery across the blood-brain barrier.
    Chaturvedi M; Molino Y; Sreedhar B; Khrestchatisky M; Kaczmarek L
    Int J Nanomedicine; 2014; 9():575-88. PubMed ID: 24531257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using microfluidic platforms to develop CNS-targeted polymeric nanoparticles for HIV therapy.
    Martins C; Araújo F; Gomes MJ; Fernandes C; Nunes R; Li W; Santos HA; Borges F; Sarmento B
    Eur J Pharm Biopharm; 2019 May; 138():111-124. PubMed ID: 29397261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of L-carnosine functionalized iron oxide nanoparticles loaded with dexamethasone for simultaneous therapeutic potential of blood brain barrier crossing and ischemic stroke treatment.
    Lu X; Zhang Y; Wang L; Li G; Gao J; Wang Y
    Drug Deliv; 2021 Dec; 28(1):380-389. PubMed ID: 33586561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Elvitegravir Nanoformulation Crosses the Blood-Brain Barrier and Suppresses HIV-1 Replication in Microglia.
    Gong Y; Zhi K; Nagesh PKB; Sinha N; Chowdhury P; Chen H; Gorantla S; Yallapu MM; Kumar S
    Viruses; 2020 May; 12(5):. PubMed ID: 32443728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iguratimod encapsulated PLGA-NPs improves therapeutic outcome in glioma, glioma stem-like cells and temozolomide resistant glioma cells.
    Younis M; Faming W; Hongyan Z; Mengmeng T; Hang S; Liudi Y
    Nanomedicine; 2019 Nov; 22():102101. PubMed ID: 31654739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ferulic acid-loaded polymeric nanoparticles prepared from nano-emulsion templates facilitate internalisation across the blood-brain barrier in model membranes.
    Garcia L; Palma-Florez S; Espinosa V; Soleimani Rokni F; Lagunas A; Mir M; García-Celma MJ; Samitier J; Rodríguez-Abreu C; Grijalvo S
    Nanoscale; 2023 May; 15(17):7929-7944. PubMed ID: 37067009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation on mechanisms of glycopeptide nanoparticles for drug delivery across the blood-brain barrier.
    Tosi G; Fano RA; Bondioli L; Badiali L; Benassi R; Rivasi F; Ruozi B; Forni F; Vandelli MA
    Nanomedicine (Lond); 2011 Apr; 6(3):423-36. PubMed ID: 21542682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular uptake of PLGA nanoparticles targeted with anti-amyloid and anti-transferrin receptor antibodies for Alzheimer's disease treatment.
    Loureiro JA; Gomes B; Fricker G; Coelho MAN; Rocha S; Pereira MC
    Colloids Surf B Biointerfaces; 2016 Sep; 145():8-13. PubMed ID: 27131092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative whole corona fingerprinting and protein adsorption thermodynamics of PLGA and PCL nanoparticles in human serum.
    Ndumiso M; Buchtová N; Husselmann L; Mohamed G; Klein A; Aucamp M; Canevet D; D'Souza S; Maphasa RE; Boury F; Dube A
    Colloids Surf B Biointerfaces; 2020 Apr; 188():110816. PubMed ID: 31991290
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Cayero-Otero MD; Gomes MJ; Martins C; Álvarez-Fuentes J; Fernández-Arévalo M; Sarmento B; Martín-Banderas L
    Expert Opin Drug Deliv; 2019 Dec; 16(12):1413-1427. PubMed ID: 31694417
    [No Abstract]   [Full Text] [Related]  

  • 15. Specific cellular internalization and pH-responsive behavior of doxorubicin loaded PLGA-PEG nanoparticles targeted with anti EGFRvIII antibody.
    Eivazi N; Rahmani R; Paknejad M
    Life Sci; 2020 Nov; 261():118361. PubMed ID: 32861796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced cancer therapy with pH-dependent and aptamer functionalized doxorubicin loaded polymeric (poly D, L-lactic-co-glycolic acid) nanoparticles.
    Saravanakumar K; Hu X; Shanmugam S; Chelliah R; Sekar P; Oh DH; Vijayakumar S; Kathiresan K; Wang MH
    Arch Biochem Biophys; 2019 Aug; 671():143-151. PubMed ID: 31283911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved mucoadhesion and cell uptake of chitosan and chitosan oligosaccharide surface-modified polymer nanoparticles for mucosal delivery of proteins.
    Dyawanapelly S; Koli U; Dharamdasani V; Jain R; Dandekar P
    Drug Deliv Transl Res; 2016 Aug; 6(4):365-79. PubMed ID: 27106502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo evaluation of enhanced drug carrier efficiency and cardiac anti-hypertrophy therapeutic potential of nano-curcumin encapsulated photo-plasmonic nanoparticles combined polymerized nano-vesicles: A novel strategy.
    Liu Y; Liu Q; Liu Y; Ju F; Ma Q; He Q
    J Photochem Photobiol B; 2019 Oct; 199():111619. PubMed ID: 31622787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-proliferate and apoptosis triggering potential of methotrexate-transferrin conjugate encapsulated PLGA nanoparticles with enhanced cellular uptake by high-affinity folate receptors.
    Parmar A; Jain A; Uppal S; Mehta SK; Kaur K; Singh B; Sandhir R; Sharma S
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):704-719. PubMed ID: 29745729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploiting Bacterial Pathways for BBB Crossing with PLGA Nanoparticles Modified with a Mutated Form of Diphtheria Toxin (CRM197): In Vivo Experiments.
    Tosi G; Vilella A; Veratti P; Belletti D; Pederzoli F; Ruozi B; Vandelli MA; Zoli M; Forni F
    Mol Pharm; 2015 Oct; 12(10):3672-84. PubMed ID: 26312414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.